AUSTIN, Texas, Dec. 21, 2021 /PRNewswire/ -- Spindletop
Health Acquisition Corp. (the "Company") (NASDAQ:SHCAU) today
announced that holders of the Company's units may elect to
separately trade the Class A common stock and warrants included in
its units commencing on or about December
27, 2021.
The Class A common stock and warrants will trade on the Nasdaq
Stock Market ("Nasdaq") under the symbols SHCA and SHCAW,
respectively. No fractional warrants will be issued upon separation
of the units and only whole warrants will trade. Units not
separated will continue to trade on Nasdaq under the symbol
SHCAU.
Holders of units will need to have their brokers contact
Continental Stock Transfer & Trust Company, the Company's
transfer agent, in order to separate the units into Class A common
stock and warrants.
A registration statement relating to the units and the
underlying securities was declared effective by the U.S. Securities
and Exchange Commission (the "SEC") on November 3, 2021.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction. A copy of the final prospectus relating to the
initial public offering may be obtained for free by visiting the
SEC website at http://www.sec.gov. Alternatively, a copy of the
prospectus related to the initial public offering may be obtained
from Barclays Capital Inc., c/o Broadridge Financial Solutions,
1155 Long Island Avenue, Edgewood,
NY 11717, by telephone: 1-888-603-5847 or by
email: Barclaysprospectus@broadridge.com; or Stifel, Nicolaus,
& Company, Incorporated, 1 South Street,
15th Floor, Baltimore,
Maryland 21202, Attn: Prospectus Department, or by emailing
syndprospectus@stifel.com.
Forward Looking Statements
This press release includes "forward-looking statements"
within the meaning of Section 27A of the Securities Act of 1933, as
amended (the "Securities Act") and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act") that are not
historical facts and involve risks and uncertainties that could
cause actual results to differ materially from those expected and
projected. All statements, other than statements of historical fact
included in this press release, including, without limitation,
regarding the Company's business strategy, are forward-looking
statements. Words such as "expect" and "intend" and variations and
similar words and expressions are intended to identify such
forward-looking statements. Such forward-looking statements relate
to future events or future performance, but reflect management's
current beliefs, based on information currently available. A number
of factors could cause actual events, performance or results to
differ materially from the events, performance and results
discussed in the forward-looking statements. For information
identifying important factors that could cause actual results to
differ materially from those anticipated in the forward-looking
statements, please refer to the risk factors section of the
Company's final prospectus for its initial public offering and its
subsequent filings with the SEC. The Company's securities filings
can be accessed on the SEC's website at www.sec.gov. Except as
expressly required by applicable securities law, the Company
disclaims any intention or obligation to update or revise any
forward-looking statements whether as a result of new information,
future events or otherwise.
Contact:
Spindletop Health Acquisition Corp.
512.961.4633
info@spindletophealth.com
View original
content:https://www.prnewswire.com/news-releases/spindletop-health-acquisition-corp-announces-that-class-a-common-stock-and-warrants-to-commence-separate-trading-on-or-about-december-27-2021-301449397.html
SOURCE Spindletop Health Acquisition Corp.